OPCU_Mammalian Cell Culture Bucket

  1. IDT Biologika Capabilities Update May 2026: Mammalian Cell Culture 5/29/2026

    This webinar provides an expert overview of how IDT Biologika leverages advanced mammalian cell culture platforms to enable efficient, scalable biopharmaceutical development and manufacturing.

  2. FUJIFILM Biotechnologies Capabilities Update May 2026: Mammalian Cell Culture 5/29/2026

    With over 30 years of experience, FUJIFILM Biotechnologies specializes in developing and manufacturing biopharmaceuticals using microbial, mammalian, and host/virus systems.

  3. Novartis Capabilities Update May 2026: Mammalian Cell Culture 5/28/2026

    Explore a global contract manufacturing network with proven regulatory success, flexible partnership models, and end-to-end capabilities spanning biologics, advanced therapies, and fill-finish to support your program.

  4. KBI Biopharma Capabilities Update May 2026: Mammalian Cell Culture 5/28/2026

    Uncover how advanced cell line development platforms, targeted integration technologies, and data-driven selection tools can accelerate biologics development from DNA to patient with greater speed, stability, and confidence.

  5. AGC Biologics Capabilities Update May 2026: Mammalian Cell Culture 5/28/2026

    See how flexible single-use manufacturing strategies can accelerate scale-up, improve efficiency, and help streamline the journey from clinical development to commercialization.